scholarly journals Postpartum hemorrhage - what the interventional radiologist should know

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Blaine E. Menon ◽  
Claire S. Kaufman ◽  
Anne M. Kennedy ◽  
Christopher R. Ingraham ◽  
Eric J. Monroe
Keyword(s):  
High Risk ◽  
Diagnostic Imaging ◽  
Minimally Invasive ◽  
Postpartum Hemorrhage ◽  
Maternal Morbidity ◽  
Imaging Features ◽  
Invasive Treatment ◽  
Interventional Radiologist ◽  
Maternal Morbidity And Mortality ◽  
The World

AbstractPostpartum hemorrhage is a leading cause of maternal morbidity and mortality around the world and can be caused by multiple etiologies. Distinguishing between the various etiologies that lead to PPH and identifying high risk features are crucial to implementing effective clinical management. In this review, the diagnostic imaging features and management principles of some of the most important causes of postpartum hemorrhage are discussed, with an emphasis on the pearls and pitfalls when minimally invasive treatment via interventional radiologic techniques are employed.

scholarly journals Pendidikan Kesehatan tentang Anemia kepada Ibu Hamil

2020 ◽  
Vol 2 (2) ◽  
pp. 94
Author(s):  
Safitri Safitri
Keyword(s):  
Developing Countries ◽  
High Risk ◽  
Pregnant Women ◽  
Maternal Morbidity ◽  
World Health ◽  
Maternal Morbidity And Mortality ◽  
The World ◽  
Before And After ◽  
Health Organization ◽  
Prevalence Of Anemia

AbstractAnemia is a major factor causing maternal morbidity and mortality in developing countries. According to the World Health Organization (WHO) the prevalence of anemia in pregnant women in developing countries is 51%. In Indonesia, based on the results of the 2018 Riskesdas survey, data on the proportion of anemia in pregnant women increased from 37.1% (2013) to 48.9% (2018). Likewise, the Jambi City, in the Puskesmas Pakuan Baru there are still pregnant women who have anemia. Target outcomes expected are: there is an increased knowledge between before and after counseling. The method used is counseling. The results of dedication are an increase in knowledge in pregnant women as an effort to prevent and recognize high risk or complications of Anemia in early pregnancy.

Minimally Invasive Treatment of Ankle Fractures in Patients at High Risk of Soft Tissue Wound Healing Complications

2018 ◽  
Vol 57 (3) ◽  
pp. 557-571 ◽  
Author(s):  
Sherif Mohamed Abdelgaid ◽  
Ahmed Fawaz Moursy ◽  
Eyad Abd Allah Elgebaly ◽  
Aly Mohamed Aboelenien
Keyword(s):  
Wound Healing ◽  
High Risk ◽  
Soft Tissue ◽  
Minimally Invasive ◽  
Ankle Fractures ◽  
Minimally Invasive Treatment ◽  
Invasive Treatment

scholarly journals Comparison of oral and vaginal misoprostol after oral mifepristone in early medical abortion

2017 ◽  
Vol 6 (3) ◽  
pp. 1007 ◽  
Author(s):  
Nithya J. ◽  
Reddi Rani P.
Keyword(s):  
Maternal Morbidity ◽  
Medical Abortion ◽  
Maternal Deaths ◽  
Unplanned Pregnancies ◽  
Maternal Morbidity And Mortality ◽  
The World ◽  
Oral Group ◽  
Acceptable Method ◽  
The Mean ◽  
Vaginal Misoprostol

Background: Abortions are still a major problem in developing countries contributing to significant maternal morbidity and mortality. WHO has reported that 53 million unplanned pregnancies result in termination each year. One third of these are performed under unsafe conditions. Deaths related to these accounts for up to about 20% of the maternal deaths that occur each year throughout the world. the main objective of the present study is to compare the efficacy, side effects and acceptability of oral and vaginal misoprostol after single oral dose of mifepristone in induction of abortion in pregnancy up to 63 days.Methods: It was a prospective randomized trial of 100 healthy women opting for termination of pregnancy with ultrasound confirmed intrauterine gestation of less than or equal to 9 weeks who were randomized in to two groups. Mifepristone 200mg was administered on day one followed by 800µg of misoprostol orally or vaginally 48 hours later. They were reviewed on day 7 and day 14 by ultrasound for completeness of abortion. If abortion was incomplete or bleeding was excessive, surgical evacuation was performed.Results: The two groups were comparable with respect to age, parity and gestational age. The mean induction abortion interval was 51.2 hours.98% of the women in both the groups had complete abortion.  Nausea (68%) and vomiting (58%) were more common in oral group. Diarrhoea (60%) was common in vaginal group. None of them had fever. Mean duration of bleeding was 9 days. 92% of the women found the procedure to be highly acceptable and would recommend it to others.Conclusions: Medical abortion with 200mg mifepristone in combination with 800µg of misoprostol either orally or vaginally 48 hours later was found to be safe, simple, effective, inexpensive, noninvasive and acceptable method.

scholarly journals The way forward

2017 ◽  
Vol 10 (1) ◽  
pp. 43-44
Author(s):  
Sandra A Lowe
Keyword(s):  
Maternal Health ◽  
Cultural Change ◽  
Maternal Morbidity ◽  
Practice Research ◽  
Obstetric Medicine ◽  
Maternal Morbidity And Mortality ◽  
The World ◽  
Health Related ◽  
Research And Education

Improving maternal health and reducing maternal morbidity and mortality into the future will require a range of health-related and non-health-related strategies. The latter include education for women, better communication, access to transport and technology and cultural change. The role of obstetric medicine practice, research and education in achieving these objectives is discussed in this article. We need to recognise that it will require improvements in health provision and access to achieve our goal of safer childbirth for women and babies throughout the world.

Predictors of Maternal Mortality and Prognostic Models in Obstetric Patients

2017 ◽  
Vol 38 (02) ◽  
pp. 191-200 ◽  
Author(s):  
Jezid Miranda ◽  
Jose Rojas-Suarez ◽  
Andrew Levinson
Keyword(s):  
High Risk ◽  
Maternal Morbidity ◽  
Prediction Models ◽  
Severity Of Illness ◽  
Scoring Systems ◽  
Morbidity And Mortality ◽  
Prognostic Models ◽  
High Risk Patients ◽  
Maternal Morbidity And Mortality ◽  
Risk Patients

AbstractThe use of predictive models has been proposed as a potential tool to reduce maternal morbidity and mortality, by aiding in the timely identification of potential high-risk patients. Prognostic models in critical care have been used to characterize the severity of illness of specific diseases. Physiological changes in pregnancy may result in general critical illness prediction models overestimating mortality in obstetric patients. Models that specifically reflect the unique characteristics of obstetric patients may have better prognostic value. Recently developed tools have focused on identifying at-risk patients before they require intensive care unit (ICU) admission to target early interventions and prevent acute clinical decompensation. The aim of the newest scoring systems, specifically designed for groups of obstetric patients receiving non-ICU care, is to reduce maternal morbidity and mortality by identifying early high-risk patients and initiating prompt effective medical responses.

Technical Strategies to Expand Stent-Graft Applicability in the Aortic Arch and Proximal Descending Thoracic Aorta

2002 ◽  
Vol 9 (2_suppl) ◽  
pp. II-32-II-38 ◽  
Author(s):  
Frank J. Criado ◽  
Marcos F. Barnatan ◽  
Youssef Rizk ◽  
Nancy S. Clark ◽  
Cecilia F. Wang
Keyword(s):  
High Risk ◽  
Minimally Invasive ◽  
Surgical Intervention ◽  
Bypass Grafting ◽  
Descending Thoracic Aorta ◽  
Invasive Treatment ◽  
Landing Zone ◽  
Aortic Pathology ◽  
Number Of Patients ◽  
Aortic Lesions

The endovascular repair of thoracic aortic pathology is on an evolutionary threshold, as advancing technologies and techniques combine to offer the interventionist expanded treatment opportunities. A variety of maneuvers are recommended to address the landing zone limitations to thoracic endografting imposed by the arch vessels: transostial bare stent placement, intentional occlusion of the arch vessel origin, vessel transposition, and bypass grafting. These adjunctive techniques can help us extend the option of a minimally invasive treatment to a greater number of patients with severe thoracic aortic lesions and comorbidities that place them at high risk for standard surgical intervention.

scholarly journals UTEROTONIC DRUGS IN THE PREVENTION OF POSTPARTUM HEMORRHAGES

2020 ◽  
pp. 69-76
Author(s):  
Z.G. Khamidullina ◽  
A.Zh. Myrzabekova ◽  
A.Zh. Syzdykova
Keyword(s):  
Caesarean Section ◽  
Postpartum Hemorrhage ◽  
Maternal Morbidity ◽  
Perinatal Period ◽  
Active Management ◽  
World Health ◽  
Maternal Deaths ◽  
The Third ◽  
The World ◽  
Health Organization

In the world practice, hemorrhages in obstetrics take leading positions within the causes of maternal morbidity and mortal ity. 800 women die every day due to childbirth complications under the data of the World Health Organization. The majority of maternal deaths occur during the perinatal period, usually within 24 hours postpartum. It is possible to prevent most of them. Lack of adequate pre-conceptional training, uncompensated extragenital diseases increase the percentage of pathological births. Consequently, practicing obstetricians-gynecologists have to face such childbirth complications as postpartum hemorrhage with increasing frequency. Uterine atonia is the main cause of postpartum hemorrhages. Uterotonic drugs administration enables to re- duce the risk of postpartum atonic hemorrhages. Particular attention should be paid to postpartum hemorrhage prevention, i.e. the use of uterotonic drugs as an integral part of the active management during the third period in natural labor and caesarean section.

scholarly journals Postpartum hemorrhage: a continuing challenge

Hematology ◽  
2015 ◽  
Vol 2015 (1) ◽  
pp. 132-137 ◽  
Author(s):  
Evelyn Lockhart
Keyword(s):  
Risk Factors ◽  
Risk Factor ◽  
Replacement Therapy ◽  
Postpartum Hemorrhage ◽  
Maternal Morbidity ◽  
Morbidity And Mortality ◽  
Obstetric Hemorrhage ◽  
Antifibrinolytic Therapy ◽  
Maternal Morbidity And Mortality ◽  
Fibrinogen Replacement Therapy

Abstract Obstetric hemorrhage remains a leading cause of maternal morbidity and mortality worldwide. Many postpartum hemorrhages (PPHs) do not have identifiable risk factors; maternity units should therefore have obstetric hemorrhageprotocols in place for all parturients as every pregnancy has the potential to be complicated by hemorrhage. This review will examine the epidemiology of PPH as well as current recommendations for key elements in obstetric hemorrhage protocols. Recent advances in hematologic management of PPH will be also be reviewed, including: (1) recognition of hypofibrinogenemia as a risk factor for severe PPH, (2) use of antifibrinolytic therapy, and (3) strategies for fibrinogen replacement therapy.

Sign in / Sign up

Export Citation Format

Share Document